Pharmacokinetics: Orders & Sat

Cheatsheet Content

### Introduction to Pharmacokinetics Pharmacokinetics (PK) describes how the body affects a drug. It involves four key processes: Absorption, Distribution, Metabolism, and Excretion (ADME). Understanding the "order" of these processes, particularly elimination, is crucial for predicting drug concentrations and dosing. ### First-Order Kinetics #### Definition In first-order kinetics, the rate of drug elimination is directly proportional to the drug concentration. A constant *fraction* of the drug is eliminated per unit of time. This is the most common kinetic model for drugs at therapeutic concentrations. #### Mechanism Enzymes and transporters involved in metabolism and excretion are not saturated. There are ample binding sites available, so as drug concentration increases, more drug molecules can interact with these systems, leading to a faster absolute rate of elimination. #### Key Features - **Constant Half-Life ($t_{1/2}$):** The time it takes for the drug concentration to decrease by half is constant, regardless of the initial concentration. - **Exponential Decay:** Drug concentration decreases exponentially over time. - **Clearance (CL):** Clearance is constant. - **Equation:** $C_t = C_0 \cdot e^{-kt}$, where $C_t$ is concentration at time $t$, $C_0$ is initial concentration, and $k$ is the elimination rate constant. #### Example Most drugs (e.g., penicillin, ibuprofen) follow first-order kinetics at therapeutic doses. ### Zero-Order Kinetics #### Definition In zero-order kinetics, the rate of drug elimination is constant, regardless of the drug concentration. A constant *amount* of drug is eliminated per unit of time. This occurs when elimination pathways become saturated. #### Mechanism Enzymes or transporters responsible for drug metabolism or excretion become saturated. Their maximum capacity ($V_{max}$) is reached, meaning they are working at their fullest possible rate. Further increases in drug concentration cannot increase the elimination rate. #### Key Features - **Variable Half-Life:** The half-life is not constant; it increases as drug concentration increases. - **Linear Decay:** Drug concentration decreases linearly over time. - **Clearance (CL):** Clearance is not constant; it decreases as concentration increases. - **Increased Risk of Toxicity:** Small increases in dose can lead to disproportionately large increases in drug concentration and potential toxicity due to the constant elimination rate. - **Equation:** $C_t = C_0 - k_0 \cdot t$, where $k_0$ is the zero-order elimination rate constant (amount/time). #### Example - **Ethanol:** At intoxicating doses, alcohol dehydrogenase is saturated. - **Phenytoin:** At therapeutic doses, its metabolism can become saturated. - **Aspirin:** At high doses. - **Warfarin:** At high doses. ### Saturation Kinetics (Michaelis-Menten Kinetics) #### Definition Saturation kinetics (also known as mixed-order or Michaelis-Menten kinetics) describes a process that transitions from first-order at low concentrations to zero-order at high concentrations. It's a more comprehensive model that encompasses both scenarios. #### Mechanism This model mathematically describes the point at which enzyme/transporter systems begin to saturate. It is characterized by two parameters: - **$V_{max}$ (Maximum Elimination Rate):** The maximum rate at which the elimination system can operate. - **$K_m$ (Michaelis Constant):** The drug concentration at which the elimination rate is half of $V_{max}$. It reflects the affinity of the enzyme for the drug. #### Key Features - **At $C \ll K_m$:** The kinetics approximate first-order (elimination rate is proportional to concentration). - **At $C \gg K_m$:** The kinetics approximate zero-order (elimination rate approaches $V_{max}$ and is constant). - **Non-linear:** The relationship between dose and steady-state concentration is non-linear. Small dose adjustments can lead to significant changes in plasma concentration, especially at concentrations near or above $K_m$. - **Equation:** Rate of Elimination = $\frac{V_{max} \cdot C}{K_m + C}$ #### Example Drugs like phenytoin, ethanol, and aspirin exhibit saturation kinetics. It's vital to recognize this for drugs with narrow therapeutic windows, as small dose increases can lead to toxicity. ### Professor's High-Yield Notes for the Exam 1. **Differentiate Clearly:** Be able to articulate the difference between first-order (constant *fraction* eliminated, constant $t_{1/2}$) and zero-order (constant *amount* eliminated, variable $t_{1/2}$). This is fundamental. 2. **Clinical Significance of Zero-Order:** Emphasize the clinical implications of zero-order kinetics: increased risk of toxicity, unpredictable plasma levels with dose changes, and prolonged drug exposure. Think about why phenytoin requires careful monitoring. 3. **Michaelis-Menten as the Bridge:** Understand that Michaelis-Menten kinetics is the underlying principle for both. At low concentrations, it *behaves* like first-order; at high concentrations, it *becomes* zero-order. 4. **Factors Affecting $K_m$ and $V_{max}$:** Briefly consider how patient factors (e.g., liver disease, genetic polymorphisms in enzymes) could alter $K_m$ or $V_{max}$ and thus shift a drug's kinetics towards saturation more easily. 5. **Steady State:** For drugs following first-order kinetics, it takes approximately 4-5 half-lives to reach steady state. For zero-order, achieving a predictable steady state is much harder and often leads to accumulation. 6. **Graphical Representation:** Mentally (or actually) sketch the concentration-time curves for both orders: exponential decay for first-order, linear decay for zero-order. This visual understanding is powerful.